His companies Dorin Cocos they received 85 million euros in 9 years for medical test reagents sold to state hospitals, especially those in Bucharest.
According to information obtained by Rise Project, prices were inflated by 300%.
According to information obtained by Rise Project, prices were inflated by 300%.
The quoted source writes that in just one day, Cocos’ companies obtained contract in total value of 18 million euros following a business with the Matei Bals Institute.
Specifically, on June 19, 2012, the institute led by Adrian Streinu-Cercel bought, by auction, laboratory reagents worth 18 million euros.
The winning companies were Meditest Global 2002, Immuno Diagnostika and Spectrum Magnamed. Subsequently, they were investigated by the National Office for Preventing and Combating Money Laundering (ONPCSB), and the inspectors established that the final beneficiary of the 18 million euros was the businessman Dorin Cocos.
The Up Dejun meal card comes with a cost of 0 and a discount of up to 50% on the main categories of products and services that your business needs. Get the offer HERE!–
In plain sight, the companies were controlled by Cocos’ relatives, that is, by his sister and brother-in-law. In one, Cocos was a direct shareholder at one time: Meditest Global 2002.
In plain sight, the companies were controlled by Cocos’ relatives, that is, by his sister and brother-in-law. In one, Cocos was a direct shareholder at one time: Meditest Global 2002.
Read more about How much did Cocos inflate the price of medical tests on Rise Project.
– .
